Health Canada Recalls Teleflex Pilling Wecksorb Neurosponge Surgical Kits Over Endotoxin Risk

Health Canada has issued a medical device recall for Presource Kits containing the Teleflex Pilling® Wecksorb Neurosponge, after distributor Cardinal Health was notified by manufacturer Teleflex of out-of-specification, or potential out-of-specification, endotoxin levels in the sponges. The recall, classified as a Type II health product recall, covers multiple surgical kit configurations used in hospital ear, nose, throat, sinus and neurosurgical procedures.

What Products Are Being Recalled?

The recall affects several Presource surgical kits distributed by Cardinal Health 200, LLC (also trading as Cardinal Health) that contain the Teleflex Pilling® Wecksorb Neurosponge component. Affected product lines include Nose/Nasal Packs (model SEN30NASHA), Functional Endoscopic Sinus Surgery (FESS) Packs (model SEN30FESHA), Craniotomy Packs (model SNE30PCJHG), and Basic Ear/Nose/Throat (ENT) Packs (model SEN30ENEUA). A total of nineteen distinct lot numbers are affected across these four kit types, spanning lots used in general hospital and personal-use surgical settings across Canada.

Why Was This Recall Issued?

According to Health Canada, Cardinal Health was recently informed of a medical device recall from Teleflex concerning the Pilling® Wecksorb Neurosponge included in these kits. The issue stems from out-of-specification, or potential out-of-specification, levels of endotoxin in the sponge material. Endotoxins are toxic substances that can trigger inflammatory or febrile reactions in patients if introduced into the body during surgical procedures, particularly when used in sensitive areas such as the sinuses or during neurosurgical operations like craniotomies.

Who Is Affected?

This recall is directed at a healthcare audience, including hospitals, surgical centers, and clinical staff who may have the affected Presource kits in inventory. Because the Wecksorb Neurosponge is used in nasal, sinus, ENT and craniotomy procedures, patients undergoing these surgeries with affected kit lots could be at risk of exposure to elevated endotoxin levels. The recall was published by Health Canada with an original publication date of July 15, 2026, though the underlying recall date recorded by the company is June 23, 2026.

What Should You Do?

Healthcare facilities and staff who have purchased or hold inventory of the affected Presource kits should immediately check their stock against the listed lot and model numbers, including SEN30NASHA, SEN30FESHA, SNE30PCJHG and SEN30ENEUA. Any affected kits should be segregated and removed from use pending further instructions from the manufacturer or distributor. Health Canada advises that consumers and healthcare providers contact the manufacturer directly if they require additional information about the recall or need guidance on returning or replacing affected products. Facilities should also document any adverse events potentially linked to use of the affected sponges and report them through their institution’s standard adverse event reporting channels, as well as to Health Canada.

Official Statement

Health Canada’s recall notice states that ‘Cardinal Health was recently informed of a medical device recall from Teleflex concerning the Pilling® Wecksorb Neurosponge referenced’ and that ‘the recall is being issued due to out-of-specification, or potential out-of-specification levels of endotoxin.’ The notice lists Cardinal Health 200, LLC, based in Waukegan, Illinois, as the responsible company, and identifies the action as a Type II recall under identification number RA-82329. Anyone with concerns about a health or safety issue involving these products is encouraged to report it to Health Canada through its official reporting channels.